SERS biosensor for ultrasensitive detection of human thyroglobulin

S. Spaziani; G. Quero; S. Managò; G. Zito; D. Terracciano; P. E. Macchia; F. Galeotti; M. Pisco; A. C. De Luca; A. Cusano

doi:10.1117/12.3014091

20 June 2024 SERS biosensor for ultrasensitive detection of human thyroglobulin

S. Spaziani, G. Quero, S. Managò, G. Zito, D. Terracciano, P. E. Macchia, F. Galeotti, M. Pisco, A. C. De Luca, A. Cusano

Author Affiliations +

Proceedings Volume 13008, Biophotonics in Point-of-Care III; 1300809 (2024) https://doi.org/10.1117/12.3014091
Event: SPIE Photonics Europe, 2024, Strasbourg, France

Abstract

The ability to make an accurate diagnosis at the time of treatment is crucial for many diseases. However, current standard diagnostic procedures can only be performed in specialised healthcare facilities. To bring diagnostic methods from a specialised laboratory to the point of treatment, many alternative methods have been proposed. One of them is surfaceenhanced Raman scattering (SERS), which offers advantageous features such as high sensitivity in biotarget detection and higher accuracy. Here, we have developed an advanced SERS platform for the ultrasensitive, rapid and highly specific identification of tumour biomarkers in liquid biopsies. Our particular focus is on the detection of Thyroglobulin (Tg), the most important tumour biomarker for the diagnosis and prognosis of thyroid cancer. Specifically, SERS-active substrates fabricated by nanosphere lithography on chip or on tips of optical fiber (OF) were functionalized with Tg Capture antibodies. Gold nanoparticles were functionalized with Detection antibodies and conjugated with a Raman reporter. The sandwich assay platform was validated in the planar configuration and a detection limit of only 7 pg/ml was successfully achieved. The same approach has been successfully demonstrated on washout fluids from fine needle aspiration biopsies of cancer patients. Finally, the functionalization strategy was translated to the LOF-SERS platform and successfully used to detect Tg concentration. The proposed SERS-assisted immunoassay platform has proven to be highly versatile and can be used with both microfluidic chip POC devices and SERS-OF-based optrodes to perform sensitive, specific and rapid ex vivo assays for Tg detection in liquid intraoperative biopsies.

Conference Presentation

Citation Download Citation

S. Spaziani, G. Quero, S. Managò, G. Zito, D. Terracciano, P. E. Macchia, F. Galeotti, M. Pisco, A. C. De Luca, and A. Cusano "SERS biosensor for ultrasensitive detection of human thyroglobulin", Proc. SPIE 13008, Biophotonics in Point-of-Care III, 1300809 (20 June 2024); https://doi.org/10.1117/12.3014091

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available